Gui Yang
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 10%
Papers in
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 6
- SARS-CoV-2 detection and testing 2
-
- Epigenetics and DNA Methylation 2
- Co-authors
- Yunbao Pan (4 shared papers)Junli Fan (3 shared papers)Shuang Guo (3 shared papers)Yueting Tang (4 shared papers)Yirong Li (4 shared papers)Yinjuan Liu (2 shared papers)Xinran Li (2 shared papers)Xinghua Long (1 shared paper)
In The Last Decade
Gui Yang
17 papers receiving 621 citations
Gui Yang's Hit Papers
Peers
Comparison fields: 5 of 93
- Infectious Diseases 343
- Modeling and Simulation 26
- Pharmacology 40
- Biological Psychiatry 10
- Neurology 57
Countries citing papers authored by Gui Yang
This map shows the geographic impact of Gui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gui Yang more than expected).
Fields of papers citing papers by Gui Yang
This network shows the impact of papers produced by Gui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gui Yang. The network helps show where Gui Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Gui Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 255 | |
| 2 | Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway Hit paper breakdown → | 2022 | 116 |
| 3 | 2020 | 45 | |
| 4 | 2020 | 42 | |
| 5 | 2022 | 37 | |
| 6 | 2021 | 23 | |
| 7 | 2022 | 23 | |
| 8 | 2024 | 22 | |
| 9 | 2020 | 21 | |
| 10 | Probiotics enhance the effect of allergy immunotherapy on regulating antigen specific B cell activity in asthma patients. | 2016 | 17 |
| 11 | 2021 | 10 | |
| 12 | 2021 | 8 | |
| 13 | 2020 | 4 | |
| 14 | 2018 | 3 | |
| 15 | 2024 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 |
About Gui Yang
Gui Yang is a scholar working on Infectious Diseases, Molecular Biology, Immunology, Physiology and Surgery, having authored 19 papers that have together received 629 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Asthma and respiratory diseases (3 papers), Immune cells in cancer (3 papers), Long-Term Effects of COVID-19 (2 papers), Allergic Rhinitis and Sensitization (2 papers), Epigenetics and DNA Methylation (2 papers) and SARS-CoV-2 detection and testing (2 papers). The work is most often cited by research in Infectious Diseases (343 citations), Modeling and Simulation (26 citations), Pharmacology (40 citations), Biological Psychiatry (10 citations) and Neurology (57 citations). Gui Yang has collaborated with scholars based in China, Hong Kong and Russia. Frequent co-authors include Yunbao Pan, Junli Fan, Shuang Guo, Yueting Tang, Yirong Li, Yinjuan Liu, Xinran Li, Xinghua Long, Jin Zhao and Hanning Hu. Their work appears in journals such as International Journal of Biological Sciences, Clinical Microbiology and Infection, Aging, Phytotherapy Research and Cell Communication and Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.